CAS 133039-73-3

Ellagic Acid Dihydrate

CAS : 133039-73-3, 476-66-4

Formule : C₁₄H₆O₈·2H₂O

Degré de pureté : >98.0%(T)(HPLC)

Couleur et forme : Light yellow to Brown to Dark green powder to crystal

Masse moléculaire : 338.22

Ref: 3B-E0375

Ellagic Acid Dihydrate

CAS : 133039-73-3

Formule : C₁₄H₁₀O₁₀

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 338.2232

Ref: IN-DA009ASS

Ellagic Acid Dihydrate

CAS : 133039-73-3

Ellagic Acid Dihydrate

Degré de pureté : ≥98%

Masse moléculaire : 338.22g/mol

Ref: 54-BUP15017

Ellagic Acid Dihydrate

CAS : 133039-73-3

Ellagic Acid Dihydrate inhibit the CYP1A1-dependent activation of benzo[a]pyrene.

Formule : C₁₄H₁₀O₁₀

Degré de pureté : 98.09%

Couleur et forme : Solid

Masse moléculaire : 338.22

Ref: TM-T9328

Ellagic acid dihydrate

CAS : 133039-73-3

Formule : C₁₄H₆O₈·2H₂O

Couleur et forme : Neat

Ref: TR-E505053

Ellagic acid dihydrate

CAS : 133039-73-3

Degré de pureté : 99.0%

Couleur et forme : Solid

Masse moléculaire : 338.224

Ref: 10-F099260

Ellagic Acid Dihydrate

CAS : 133039-73-3

Ellagic acid is a potent inhibitor of the uptake of carbon nanotubes in animals. It also has antiviral properties, which may be due to its reactive oxygen species-generating properties. Ellagic acid has been shown to inhibit the proliferation of human T cells in vitro and induce apoptosis. This compound also inhibits the growth of cervical cancer cells and blocks viral replication by inhibiting viral protein synthesis. Ellagic acid can be used as a structural biology probe to investigate the reaction between cellulose derivatives and molecules. It is also used in pharmaceutical preparations such as anti-cancer drugs and treatments for herpes simplex type I virus infections.

Formule : C₁₄H₆O₈·2H₂O

Degré de pureté : Min. 95%

Masse moléculaire : 338.22 g/mol

Ref: 3D-IFA03973